Peptide profile
Tetrapeptide-7 (Rigin)
Tetrapeptide-7 for extracellular matrix repair
Compare Tetrapeptide-7 (Rigin) with other peptides →Summary
A tiny protein that calms skin and helps it look fresh.
- Typical dose
- 2-4% concentration (often paired with Matrixyl) 1-2x daily
- Route
- Topical
- Cycle length
- Ongoing
- Evidence
- Limited human data
Mechanism
How it works
Rigin works like a two-handed tool — one hand reduces inflammation (calming skin), the other rebuilds collagen (restoring structure).
Tetrapeptide-7 is a synthetic peptide that mimics the endogenous protein SPARC, modulating interleukin production and extracellular matrix synthesis.
Reported in research
Benefits
- Calms red, puffy skin
- Helps make collagen, which keeps skin strong
- Fixes skin hurt by the sun
- Makes skin firmer and bouncier
Context, not a prescription
Dosing
- Typical range
- 2-4% concentration (often paired with Matrixyl) 1-2x daily (Topical)
- Cycle length
- Ongoing
Safety
Side effects & contraindications
Possible side effects
- Minimal; very well tolerated
- Mild irritation
Contraindications
- Known peptide sensitivity
Research information, not medical advice. Always consult a licensed clinician before considering any peptide.
In depth
Full profile
What it does
Less swelling, firmer skin, smoother feel, and less sun damage.
How it works
Rigin works like a tool with two hands. One hand calms the skin. The other hand rebuilds collagen to make skin strong.
It turns down the signals that cause skin swelling. At the same time, it tells skin cells to make more collagen and other building blocks.
What to expect
You can see changes in about 4-6 weeks.
- Weeks 2-3: Less redness and less touchy skin.
- Weeks 4-6: Smoother and firmer skin.
- Weeks 8-10: Fewer tiny lines and less sun damage.
Good to know
- Test it on a small skin spot first
Staying safe
- Almost none; very gentle on skin
Avoid if you have:
- People who react badly to peptides
Mechanism of action
Tetrapeptide-7 is a synthetic peptide that mimics the endogenous protein SPARC, modulating interleukin production and extracellular matrix synthesis.
Downregulates IL-1α, IL-6, and TNF-α while upregulating collagen and fibronectin synthesis in fibroblasts.
Pharmacodynamics
Visible improvement at 4-6 weeks.
Reduced inflammation, firmer skin, improved texture, less sun damage.
Timeline
- Weeks 2-3: Reduced redness and sensitivity.
- Weeks 4-6: Improved skin texture and firmness.
- Weeks 8-10: Reduced fine lines and sun damage.
Comparisons
- Rigin — effectiveness High, safety Excellent, cost $$, Very Easy to use
- Matrixyl — effectiveness High, safety Excellent, cost $$, Very Easy to use
Adverse effects
Common:
- Minimal; very well tolerated
Rare:
- Mild irritation
Contraindications & risk mitigation
Contraindicated in:
- Known peptide sensitivity
- Patch test first
Qué hace
Menos hinchazón, piel más firme, textura más suave y menor daño solar.
Cómo funciona
Rigin funciona como una herramienta con dos manos. Una mano calma la piel. La otra mano reconstruye el colágeno para fortalecerla.
Reduce las señales que causan hinchazón en la piel. Al mismo tiempo, le indica a las células cutáneas que produzcan más colágeno y otros componentes estructurales.
Qué esperar
Puedes notar cambios en unas 4-6 semanas.
- Semanas 2-3: Menos enrojecimiento y piel menos sensible.
- Semanas 4-6: Piel más suave y firme.
- Semanas 8-10: Menos líneas finas y menos daño solar.
Bueno saber
- Prueba una pequeña zona de la piel primero
Manteniéndose seguro
- Casi ninguno; muy suave con la piel
Evitar si tienes:
- Personas que reaccionan mal a los péptidos
Mecanismo de acción
El Tetrapeptide-7 es un péptido sintético que imita la proteína endógena SPARC, modulando la producción de interleucinas y la síntesis de la matriz extracelular.
Disminuye la IL-1α, IL-6 y TNF-α, mientras aumenta la síntesis de colágeno y fibronectina en los fibroblastos.
Farmacodinamia
Mejora visible a las 4-6 semanas.
Inflamación reducida, piel más firme, textura mejorada, menor daño solar.
Cronología
- Semanas 2-3: Reducción del enrojecimiento y la sensibilidad.
- Semanas 4-6: Mejora de la textura y firmeza de la piel.
- Semanas 8-10: Reducción de líneas finas y daño solar.
Comparaciones
- Rigin — efectividad Alta, seguridad Excelente, costo $$, Muy fácil de usar
- Matrixyl — efectividad Alta, seguridad Excelente, costo $$, Muy fácil de usar
Efectos adversos
Comunes:
- Mínimos; muy bien tolerado
Raros:
- Irritación leve
Contraindicaciones y mitigación de riesgos
Contraindicado en:
- Sensibilidad conocida a péptidos
- Realizar prueba de parche primero
Reference data
Specifications
- Route
- Topical
- Cycle length
- Ongoing
FAQ
Common questions
Is Rigin the same as Matrixyl?
No, Matrixyl is pentapeptide-4. Rigin is tetrapeptide-7. They work synergistically and are often combined.
Is it good for sensitive skin?
Yes, because it reduces inflammation, it's excellent for sensitive or rosacea-prone skin.
What is the evidence level?
This compound is classified as Limited human data. Some human data exists but trials are small, short-term, or not yet replicated.
Research
Research & sources
Current evidence for Tetrapeptide-7 (Rigin) is rated as Limited human data. Limited human data is available.
- 1. Tetrapeptide-7 in skin repair (2005) — DOI:10.1111/j.1468-2494.2005.00245.x
- 2. SPARC peptide analogs (2019) — DOI:10.1111/jocd.12703
- 3. Tetrapeptide-7 in skin repair (2005)
- 4. SPARC peptide analogs (2019)